Lantheus Holdings, Inc. - stock earnings
LNTH Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 1, 2024 BeforeMarket | - / - | 354.4 million | - / 377.7 million | 385.2 million |
LNTH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 131.1 million USD | 370.0 million USD |
| 2023Q4 | 103.4 million USD | 354.0 million USD |
| 2023Q3 | 132.0 million USD | 319.9 million USD |
| 2023Q2 | 94.1 million USD | 321.7 million USD |
| 2023Q1 | -2.8 million USD | 300.8 million USD |
| 2022Q4 | -119.2 million USD | 263.2 million USD |
| 2022Q3 | 61.2 million USD | 239.3 million USD |
| 2022Q2 | 43.1 million USD | 223.7 million USD |
| 2022Q1 | 43.0 million USD | 208.9 million USD |
| 2021Q4 | -40.2 million USD | 129.6 million USD |
| 2021Q3 | -13.4 million USD | 102.1 million USD |
| 2021Q2 | -26.7 million USD | 101.1 million USD |
| 2021Q1 | 9.0 million USD | 92.5 million USD |
| 2020Q4 | -3.4 million USD | 94.2 million USD |
| 2020Q3 | -6.4 million USD | 88.5 million USD |
| 2020Q2 | -7.0 million USD | 66.0 million USD |
| 2020Q1 | 3.3 million USD | 90.7 million USD |
| 2019Q4 | 10.5 million USD | 89.3 million USD |
| 2019Q3 | 4.9 million USD | 85.8 million USD |
| 2019Q2 | 6.4 million USD | 85.7 million USD |
| 2019Q1 | 9.9 million USD | 86.5 million USD |
| 2018Q4 | 13.3 million USD | 86.3 million USD |
| 2018Q3 | 9.3 million USD | 88.9 million USD |
| 2018Q2 | 9.7 million USD | 85.6 million USD |
| 2018Q1 | 8.2 million USD | 82.6 million USD |
| 2017Q4 | 97.1 million USD | 81.2 million USD |
| 2017Q3 | 8.5 million USD | 79.9 million USD |
| 2017Q2 | 13.6 million USD | 88.8 million USD |
| 2017Q1 | 4.1 million USD | 81.4 million USD |
| 2016Q4 | 4.9 million USD | 74.4 million USD |
| 2016Q3 | 4.2 million USD | 73.1 million USD |
| 2016Q2 | 7.4 million USD | 78.0 million USD |
| 2016Q1 | 10.3 million USD | 76.5 million USD |
| 2015Q4 | 3.9 million USD | 71.2 million USD |
| 2015Q3 | 5.4 million USD | 74.1 million USD |
| 2015Q2 | -24.4 million USD | 73.3 million USD |
| 2015Q1 | 375000 USD | 74.8 million USD |
| 2014Q4 | 227000 USD | 77.0 million USD |
| 2014Q3 | -867000 USD | 75.7 million USD |
| 2014Q2 | -1.6 million USD | 75.6 million USD |
| 2014Q1 | -1.3 million USD | 73.3 million USD |
| 2013Q4 | -12.3 million USD | 71.7 million USD |
| 2013Q3 | -15.1 million USD | 70.4 million USD |
| 2013Q2 | -14.4 million USD | 70.6 million USD |
| 2013Q1 | -19.8 million USD | 71.0 million USD |
| 2012Q4 | -9.6 million USD | 72.2 million USD |
LNTH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 326.7 million USD | 1.3 billion USD |
| 2022 | 28.1 million USD | 935.1 million USD |
| 2021 | -71.3 million USD | 425.2 million USD |
| 2020 | -13.5 million USD | 339.4 million USD |
| 2019 | 31.7 million USD | 347.3 million USD |
| 2018 | 40.5 million USD | 343.4 million USD |
| 2017 | 123.4 million USD | 331.4 million USD |
| 2016 | 26.8 million USD | 301.9 million USD |
| 2015 | -14.7 million USD | 293.5 million USD |
| 2014 | -3.6 million USD | 301.6 million USD |
| 2013 | -61.6 million USD | 283.7 million USD |
| 2012 | -42.0 million USD | 288.1 million USD |
| 2011 | -137.3 million USD | 356.3 million USD |
LNTH
Price: $78.22
52 week price:
Earnings Per Share: 4.65 USD
P/E Ratio: 36.66
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 24390
Ebitda: 17.5 millionMarket Capitalization: 5.3 billion